Free Trial

Relmada Therapeutics (RLMD) Insider Trading & Ownership

→ The new financial threat that could wipe out millions… (From InvestorPlace) (Ad)
Free RLMD Stock Alerts
$3.82
0.00 (0.00%)
(As of 10:09 AM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability

Relmada Therapeutics (NASDAQ:RLMD) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
18.00%
Number Of
Insiders Buying
(Last 12 Months)
4
Amount Of
Insider Buying
(Last 12 Months)
$382,104.61
Number Of
Insiders Selling
(Last 12 Months)
0
Get RLMD Insider Trade Alerts

Want to know when executives and insiders are buying or selling Relmada Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

RLMD Insider Buying and Selling by Quarter

Ad InvestorPlace
The new financial threat that could wipe out millions…
During the Internet boom, companies like Pets.com were supposed to be promising investments riding the wave of a new tech boom. But then they were gone within a blink of an eye. One of the most successful investors in history just stepped forward to say the same thing is about to happen to AI stocks.
Pay close attention to this important video

Relmada Therapeutics Insider and Congressional Trades History

Export to Excel
Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
1/31/2024Maged ShenoudaCFOBuy6,875$4.06$27,912.50  
1/31/2024Sergio TraversaCEOBuy27,460$4.00$109,840.00  
1/30/2024Chuck EnceInsiderBuy14,500$3.87$56,115.00  
1/29/2024Maged ShenoudaCFOBuy10,800$3.65$39,420.00  
1/29/2024Sergio TraversaCEOBuy31,541$3.71$117,017.11  
5/23/2023Cedric O'gormanInsiderBuy10,000$3.18$31,800.00  
(Data available from 1/1/2013 forward)

RLMD Insider Trading Activity - Frequently Asked Questions

Who is on Relmada Therapeutics's Insider Roster?

The list of insiders at Relmada Therapeutics includes Cedric O'gorman, Charles J Casamento, Chuck Ence, Maged Shenouda, Paul Edward Kelly, and Sergio Traversa. Learn more on insiders at RLMD.

What percentage of Relmada Therapeutics stock is owned by insiders?

18.00% of Relmada Therapeutics stock is owned by insiders. Learn more on RLMD's insider holdings.

Which Relmada Therapeutics insiders have been buying company stock?

The following insiders have purchased RLMD shares in the last 24 months: Cedric O'gorman ($31,800.00), Chuck Ence ($56,115.00), Maged Shenouda ($67,332.50), and Sergio Traversa ($342,882.11).

How much insider buying is happening at Relmada Therapeutics?

Insiders have purchased a total of 156,426 RLMD shares in the last 24 months for a total of $498,129.61 bought.

Which Relmada Therapeutics insiders have been selling company stock?

The following insider sold RLMD shares in the last 24 months: Sergio Traversa ($306,309.56).

How much insider selling is happening at Relmada Therapeutics?

Insiders have sold a total of 16,012 Relmada Therapeutics shares in the last 24 months for a total of $306,309.56 sold.


More Insider Trading Tools from MarketBeat

Related Companies:
Insider Tracking Tools:
Insider Trading By Country:
Latest Articles:
This page (NASDAQ:RLMD) was last updated on 5/8/2024 by MarketBeat.com Staff

From Our Partners
The Department of Defense Has a New Drone Contractor
The Tomorrow Investor
Tech GIANT’s Plans to Revolutionize Crypto…
Crypto 101 Media
Shocking: One AI startup's revenue could surge 4,735%
Manward Press
AI “wealth window” is closing June 25th
Paradigm Press
Claim Your Complimentary Bitcoin Reward
Crypto Swap Profits
Gold Set to EXPLODE!
Gold Safe Exchange
The #1 lithium battery stock to have on your radar in 2024!
Smallcaps Daily
Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years
Banyan Hill Publishing